Skip to main content
Retour
Watch Compare

Tevogen Bio Holdings Inc.

Qualité des données : 83%
Également cotée sous TVGNW NASDAQ
TVGN
NASDAQ Manufacturing Chemicals
5,74 €
▲ 0,01 € (0,17%)
Cap. Boursière: 24,07 M
Prix
5,78 €
Cap. Boursière
24,07 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -12,39 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,31
Interest Coverage-133,63

Valorisation

PE (TTM)
-0,92
Au-dessus de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -0,9 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

1 analyste
Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -13,00 €
-13,00 € – -13,00 €
 0,0 1
FY2026 -10,00 €
-10,00 € – -10,00 €
 0,0 1

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -1,50 € -7,96 € -430,7%
Q32025 -3,00 € -1,50 € +50,0%
Q22025 -2,50 € -1,50 € +40,0%
Q12025 -2,50 € -3,50 € -40,0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -26,28 M
ROE N/A ROA -599,70%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -12,39 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,31
Interest Coverage -133,63 Asset Turnover N/A
Working Capital -4,62 M Tangible Book Value -7,82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,92 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -51,49%
Market Cap 24,07 M Enterprise Value 24,07 M
Per Share
EPS (Diluted TTM) -8,08 Revenue / Share N/A
FCF / Share -2,98 OCF / Share -2,96
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 47,17%
SBC-Adj. FCF -29,50 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue — — — — —
Net Income -26,28 M -13,73 M -67 325,0 -28 745,0 4,41 M
EPS (Diluted) -8,08 -0,07 — — —
Gross Profit — — — — —
Operating Income -26,14 M -53,56 M — — —
EBITDA — — — — —
R&D Expenses 11,11 M 31,03 M — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense -195 618,0 184 037,0 256 031,0 — —
Income Tax 4 750,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 4,38 M 3,46 M 17,04 M 352,85 M 357,14 M
Total Liabilities 12,62 M 10,14 M 17,73 M 15,18 M 15,06 M
Shareholders' Equity -8,23 M -6,67 M -17,38 M -14,23 M -14,78 M
Total Debt — — 0,0 — —
Cash & Equivalents 0,0 0,0 — 344 581,0 129 186,0
Current Assets 1,54 M 2,36 M 355 836,0 791 191,0 274 356,0
Current Liabilities 7,07 M 9,04 M 3,00 M 59 375,0 350 454,0